Seoul, South Korea

Sang-A Lee

This inventor holds 1 USPTO granted patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang-A Lee. Retrieved from https://idiyas.com/inventor/sang-a-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sang-A Lee

Introduction

Sang-A Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on doripenem crystals. His expertise and dedication to research have led to advancements that benefit the medical community.

Latest Patents

Sang-A Lee holds a patent for a novel doripenem crystal, specifically titled "Crystal of doripenem, and preparation method therefor." This invention relates to a unique doripenem crystal, a solvate thereof, and a preparation method. More specifically, it focuses on a novel doripenem anhydride crystal and the method of preparing this crystal using various solvents.

Career Highlights

Sang-A Lee is currently associated with Jw Pharmaceutical Corporation, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new formulations that enhance the efficacy of existing medications.

Collaborations

Throughout his career, Sang-A Lee has collaborated with notable colleagues, including Do-Kyu Pyun and Kyoung-Jin O. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sang-A Lee's contributions to the field of pharmaceuticals, particularly through his patent on doripenem crystals, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…